Type 1 diabetes Nutritional, Metabolic, Endocrine Insulin-dependent diabetes mellitus
Conditions
Interventions
Two DAFNE centres in UK will be involved in this study. Professor Simon Heller is lead consultant involved in this study based in the University of Sheffield and Dr Ian Lawrence is lead Consultant Dia
Sponsors
Sheffield Teaching Hospitals NHS Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with type 1 diabetes and a duration of 12 months 2. Both males and females patients who were 18 years old or greater at recruitment 3. Patients attending the adult diabetes clinic in one of the participating DAFNE centres 4. Patients who could speak and read English 5. Patients who are currently enrolled for a DAFNE programme in one of the participating DAFNE centres
Exclusion criteria
Exclusion criteria: 1. Patients with type 2 diabetes 2. Patients attending a paediatric clinic 3. Patients who are pregnant or planning a pregnancy in the next 2 years 4. Patients who have advanced diabetic complications (e.g. kidney failure with serum creatinine >250 µmol/L) 5. Patients with serious comorbidity likely to interfere with study participation 6. Patients who have had previous DAFNE training or current use of a continuous subcutaneous insulin infusion pump
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| As the study is entirely qualitative and explorative the main outcomes will emerge through analysing the interview data. Baseline qualitative data will be analysed in November 2011 and 6-month data will be analysed in May 2012 | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome measures | — |
Countries
Germany, Ireland, United Kingdom
Outcome results
None listed